BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

93 related articles for article (PubMed ID: 14981761)

  • 1. Mechanisms of coxsackievirus B5 mediated beta-cell death depend on the multiplicity of infection.
    Rasilainen S; Ylipaasto P; Roivainen M; Lapatto R; Hovi T; Otonkoski T
    J Med Virol; 2004 Apr; 72(4):586-96. PubMed ID: 14981761
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Mechanisms of beta cell death during restricted and unrestricted enterovirus infection.
    Rasilainen S; Ylipaasto P; Roivainen M; Bouwens L; Lapatto R; Hovi T; Otonkoski T
    J Med Virol; 2004 Mar; 72(3):451-61. PubMed ID: 14748069
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Mechanisms of coxsackievirus-induced damage to human pancreatic beta-cells.
    Roivainen M; Rasilainen S; Ylipaasto P; Nissinen R; Ustinov J; Bouwens L; Eizirik DL; Hovi T; Otonkoski T
    J Clin Endocrinol Metab; 2000 Jan; 85(1):432-40. PubMed ID: 10634421
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Complete nucleotide sequence of a Coxsackievirus B-4 strain capable of establishing persistent infection in human pancreatic islet cells: effects on insulin release, proinsulin synthesis, and cell morphology.
    Yin H; Berg AK; Westman J; Hellerström C; Frisk G
    J Med Virol; 2002 Dec; 68(4):544-57. PubMed ID: 12376963
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Enterovirus-induced gene expression profile is critical for human pancreatic islet destruction.
    Ylipaasto P; Smura T; Gopalacharyulu P; Paananen A; Seppänen-Laakso T; Kaijalainen S; Ahlfors H; Korsgren O; Lakey JR; Lahesmaa R; Piemonti L; Oresic M; Galama J; Roivainen M
    Diabetologia; 2012 Dec; 55(12):3273-83. PubMed ID: 22983635
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Slow Infection due to Lowering the Amount of Intact versus Empty Particles Is a Characteristic Feature of Coxsackievirus B5 Dictated by the Structural Proteins.
    Turkki P; Laajala M; Stark M; Vandesande H; Sallinen-Dal Maso H; Shroff S; Sävneby A; Galitska G; Lindberg AM; Marjomäki V
    J Virol; 2019 Oct; 93(20):. PubMed ID: 31375587
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Coxsackievirus B3 infection and type 1 diabetes development in NOD mice: insulitis determines susceptibility of pancreatic islets to virus infection.
    Drescher KM; Kono K; Bopegamage S; Carson SD; Tracy S
    Virology; 2004 Nov; 329(2):381-94. PubMed ID: 15518817
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Functional impairment and killing of human beta cells by enteroviruses: the capacity is shared by a wide range of serotypes, but the extent is a characteristic of individual virus strains.
    Roivainen M; Ylipaasto P; Savolainen C; Galama J; Hovi T; Otonkoski T
    Diabetologia; 2002 May; 45(5):693-702. PubMed ID: 12107750
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Inflammatory gene expression in Coxsackievirus B-4-infected human islets of Langerhans.
    Olsson A; Johansson U; Korsgren O; Frisk G
    Biochem Biophys Res Commun; 2005 May; 330(2):571-6. PubMed ID: 15796921
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Infection of human islets of Langerhans with two strains of Coxsackie B virus serotype 1: assessment of virus replication, degree of cell death and induction of genes involved in the innate immunity pathway.
    Anagandula M; Richardson SJ; Oberste MS; Sioofy-Khojine AB; Hyöty H; Morgan NG; Korsgren O; Frisk G
    J Med Virol; 2014 Aug; 86(8):1402-11. PubMed ID: 24249667
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Adenoviral transfection of isolated pancreatic islets: a study of programmed cell death (apoptosis) and islet function.
    Weber M; Deng S; Kucher T; Shaked A; Ketchum RJ; Brayman KL
    J Surg Res; 1997 Apr; 69(1):23-32. PubMed ID: 9202642
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Antiviral treatment of Coxsackie B virus infection in human pancreatic islets.
    Berg AK; Olsson A; Korsgren O; Frisk G
    Antiviral Res; 2007 Apr; 74(1):65-71. PubMed ID: 17239967
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Coxsackie B viruses use multiple receptors to infect human cardiac cells.
    Orthopoulos G; Triantafilou K; Triantafilou M
    J Med Virol; 2004 Oct; 74(2):291-9. PubMed ID: 15332279
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Tumor necrosis factor-alpha-activated cell death pathways in NIT-1 insulinoma cells and primary pancreatic beta cells.
    Stephens LA; Thomas HE; Ming L; Grell M; Darwiche R; Volodin L; Kay TW
    Endocrinology; 1999 Jul; 140(7):3219-27. PubMed ID: 10385418
    [TBL] [Abstract][Full Text] [Related]  

  • 15. dsRNA formed as an intermediate during Coxsackievirus infection does not induce NO production in a beta-cell line with or without addition of IFN-gamma.
    Berg AK; Elshebani A; Andersson A; Frisk G
    Biochem Biophys Res Commun; 2005 Feb; 327(3):780-8. PubMed ID: 15649414
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Coxsackieviral-mediated diabetes: induction requires antigen-presenting cells and is accompanied by phagocytosis of beta cells.
    Horwitz MS; Ilic A; Fine C; Balasa B; Sarvetnick N
    Clin Immunol; 2004 Feb; 110(2):134-44. PubMed ID: 15003810
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Pathogenesis of coxsackievirus-B5 acquired from intra-renal porcine islet cell xenografts in diabetic mice.
    Myers SE; LaRue R; Shaw DP; Love BC; M KN
    Xenotransplantation; 2009; 16(2):91-8. PubMed ID: 19392724
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Enterovirus infection induces cytokine and chemokine expression in insulin-producing cells.
    Nair S; Leung KC; Rawlinson WD; Naing Z; Craig ME
    J Med Virol; 2010 Nov; 82(11):1950-7. PubMed ID: 20872723
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Coxsackievirus B5 Infection Induces Dysregulation of microRNAs Predicted to Target Known Type 1 Diabetes Risk Genes in Human Pancreatic Islets.
    Kim KW; Ho A; Alshabee-Akil A; Hardikar AA; Kay TW; Rawlinson WD; Craig ME
    Diabetes; 2016 Apr; 65(4):996-1003. PubMed ID: 26558682
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Target cell defense prevents the development of diabetes after viral infection.
    Flodström M; Maday A; Balakrishna D; Cleary MM; Yoshimura A; Sarvetnick N
    Nat Immunol; 2002 Apr; 3(4):373-82. PubMed ID: 11919579
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.